DOCSLIB.ORG

Fertility2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fertility2017 The AssociationACE of Clinical Embryologists Fertility 2017 Fertility2017 5-7 JANUARY 2017 Edinburgh International Conference handbookConference Conference Centre (EICC) #fertility2017 CONFERENCE HANDBOOK Affiliated Organisations: Supported by: Fertility2017 The AssociationACE of Clinical Embryologists VENUE PLAN VENUE PLAN Level 3 VENUE PLAN PENTLAND PROGRAMME SIDLAW FINTRY PROGRAMME INFORMATION CONFERENCE CONFERENCE INFORMATION AND BIOGRAPHIES SPEAKER ABSTRACTS PREVIEW LOMOND FOYER SOUTRA Level 0 ABSTRACTS Moorfoot AND BIOGRAPHIES Kilsy PRESENTATIONS Tinto LOMOND SUITE th POSTER L L A H Business E N Centre A L B H T A POSTER R REGISTRATION T S O T PRESENTATIONS S K N I L STRATHBLANE HALL ATRIUM EXHIBITOR LIST LIST EXHIBITOR MAIN ENTRANCE EXHIBITION PLAN PLAN Level -2 EXHIBITION INFORMATION EXHIBITOR CROMDALE HALL LENNOX SUITE EXHIBITOR INFORMATION EXHIBITION, POSTERS AND CATERING SPEAKER INDEX Bar INDEX SPEAKER Moffat 12 Lammermuir 2 #fertility2017 Fertility2017 The AssociationACE of Clinical Embryologists CHAIR’S WELCOME VENUE PLAN A warm welcome to Edinburgh and to the International Conference Centre for Fertility 2017. This is the tenth joint Fertility meeting organised by the Association of Clinical Embryologists (ACE), the British Fertility Society (BFS) and the Society for Reproduction and Fertility (SRF). As always, we have attempted to organise an VENUE PLAN exciting scientific programme which appeals to scientists, clinicians, embryologists, nurses and counsellors. I hope you agree there is something for everyone. PROGRAMME The theme for Fertility 2017 is the Ovary with plenary sessions on Developmental and environmental impacts on the ovary, Oocytes, and Ovarian function/dysfunction. There will also be 3 eponymous lectures: The Anne McLaren Memorial Lecture, the Howard Jacobs Lecture and the Bob Edwards Memorial Lecture. These, together with the Update sessions, will allow renowned experts to present their latest data in a wide range of topics of interest to delegates. PROGRAMME Fertility 2017 is set to be the most successful yet, having an unprecedented number of abstract submissions and delegates registered. Consequently, competition to present in the parallel, short oral communication sessions was immense. We are INFORMATION CONFERENCE also in the fortunate position to have a large number of high quality abstracts being presented during the poster sessions. The social events are an integral part of Fertility 2017 providing delegates with an excellent opportunity to network and discuss science. This year we are taking a break from the usual football tournament and instead have organised ten pin bowling followed by a meal. The venue for dinner on Thursday evening is the Caves where you will experience the historic CONFERENCE 18th Century South Bridge Vaults. Finally, on Friday the conference dinner will be held at the Conference Centre and followed INFORMATION by a traditional Ceilidh band. AND BIOGRAPHIES Organising Fertility 2017 has very much been a team effort and I would particularly like to thank members of the joint ABSTRACTS Programme Committee who have worked diligently to prepare what I hope you will agree is an outstanding scientific programme. I would also like to thank the Conference organisers, Profile Productions and the many sponsors and exhibitors. It is a pleasure to welcome you to the Fertility 2017 conference and the beautiful city of Edinburgh. I hope you find the meeting both enjoyable and scientifically rewarding. ABSTRACTS AND BIOGRAPHIES Dr Franchesca Houghton PRESENTATIONS Fertility 2017 and SRF Programme Committee Chair POSTER University of Southampton POSTER Conference organisers: PRESENTATIONS ACKNOWLEDGEMENTS Profile Productions Ltd EXHIBITOR Profile Productions Ltd, Boston House, LIST Association of Clinical 69-75 Boston Manor Road, Brentford, Middlesex, TW8 9JJ Embryologists LIST The AssociationAC of Clinical EmbryologistEs c/o Profile Productions Ltd, Tel: +44(0)20 3725 5840 EXHIBITOR Boston House, 69-75 Boston Manor Fax: +44(0)84 4507 0578 Road, Brentford, Middlesex, TW8 9JJ Email: [email protected] Tel: +44(0)20 3725 5840 Website: www.profileproductions.co.uk EXHIBITION Fax: +44(0)84 4507 0578 PLAN Email: [email protected] Website: www.embryologists.org.uk CONTENTS PLAN British Fertility Society EXHIBITION Conference programme 4-11 c/o Profile Productions Ltd, Boston House, 69-75 Boston Manor Conference information 13 INFORMATION EXHIBITOR Road, Brentford, Middlesex, TW8 9JJ Speaker abstracts and biographies Tel: +44(0)20 3725 5849 Fax: +44(0)84 4507 0578 - Plenary speakers 14-19 Email: [email protected] 21-33 - Update sessions EXHIBITOR Website: www.britishfertilitysociety.org.uk INFORMATION - Short papers 36-68 Society for Reproduction - Exhibitors symposia 69 SPEAKER and Fertility Poster presentations 70-153 INDEX c/o Conference Collective, 8 Waldegrave Road, Teddington, Exhibitor list 154 INDEX Middlesex, TW11 8GT Exhibition plan 155 SPEAKER Tel: +44(0)20 8977 7997 Exhibitor information 156-162 Email: [email protected] Website: www.srf-reproduction.org Speaker index 163 3 #fertility2017 Fertility2017 The AssociationACE of Clinical Embryologists CONFERENCE PROGRAMME VENUE PLAN Wednesday 4 January 17.00 Ten pin bowling at Fountain Park VENUE PLAN 19.00 After at Akva! PROGRAMME Thursday 5 January 08.00 Registration, refreshments, exhibition and poster presentations PENTLAND PLENARY SESSION - Developmental and environmental impacts on the ovary PROGRAMME 09.15 Chair’s welcome Dr Franchesca Houghton, Fertility 2017 Programme Chair and Associate Professor in Stem Cells and INFORMATION CONFERENCE Developmental Biology, University of Southampton 09.25 Development of the ovary and rescue after chemotherapy Prof Blanche Capel, Professor of Cell Biology, Duke University Medical Centre, USA 09.55 How the environment affects ovarian function and the oocyte CONFERENCE Dr Roger Sturmey, Senior Lecturer in Reproductive Medicine, Hull York Medical School INFORMATION 10.25 AND BIOGRAPHIES Replenishing the adult ovarian follicular population: Isolation and characterisation of germ line stem cells ABSTRACTS from adult women Prof Evelyn Telfer, Personal Chair in Reproductive Biology, University of Edinburgh 11.05 Exhibition, refreshments and attended poster presentations of odd numbered posters ABSTRACTS 12.00 PENTLAND PLENARY SESSION - The Anne McLaren Memorial Lecture AND BIOGRAPHIES Chair: Dr Tony Michael, Director of Taught Programmes (Biological & Chemical Sciences) and Reader in PRESENTATIONS Reproductive Biology, Chair, Society of Reproduction and Fertility POSTER The role of sister germ cells in oocyte differentiation Dr Allan Spradling, Department of Embryology, Carnegie Institution for Science/ HHMI, Baltimore, USA POSTER 13.00-13.45 SRF AGM FINTRY PRESENTATIONS 13.00 Lunch, exhibition and poster presentations EXHIBITOR LIST 14.15-15.45 Short paper SESSIONS A A1 Emerging strategies in ART FINTRY LIST Chair: Dr James Nicopollous, Consultant Gynaecologist, The Lister Hospital, London and Dr Yacoub Khalaf, EXHIBITOR Guy’s and St Thomas’ Hospital 14.15 Multilocus genetic risk scores for poor ovarian response - Joaquin Llácer, Instituto Bernabeu Biotech, Spain EXHIBITION 14.30 For women undergoing double embryo transfer on day five, the addition of a poor quality embryo may have PLAN a detrimental effect on assisted reproduction outcome - Alison Richardson, University of Nottingham 14.45 A second injection of kisspeptin-54 safely improves oocyte maturation during in vitro fertilisation therapy in women at high risk of ovarian hyperstimulation syndrome - Ali Abbara, Imperial College London PLAN EXHIBITION 15.00 Progesterone assay concentrations to guide whether to proceed to a fresh embryo transfer or to freeze all suitable embryos are insufficiently reliable - Jennifer Lyon, GCRM, Glasgow INFORMATION 15.15 EXHIBITOR The clinical value of time-lapse as an efficacious embryo selection tool: A systematic literature review and meta-analysis of 45 studies involving 28876 embryos - Stephanie Yip, Imperial College London 15.30 Intralipid infusion does not result in improved live birth rates in women with recurrent implantation failure undergoing IVF treatment and is associated with an increased risk of congenital fetal malformations: a EXHIBITOR double blinded randomised controlled trial - Islam Gamaleldin, University of Bristol INFORMATION A2 Sperm integrity and function MOORFOOT SPEAKER Chair: Prof Allan Pacey, Editor, Human Fertility and Prof Chris Barrett, University of Dundee INDEX 14.15 SRF/SRB Exchange paper: Cellular samurais and sperm: Katnal2 is an essential regulator of microtubules in haploid male germ cells and INDEX sertoli cells - Jessica Dunleavy, Monash University, Australia SPEAKER 14.30 Does exposure to cisplatin impair survival and proliferation of spermatogonial stem cells in prepubertal mouse testis? - Frederica Lopes, University of Edinburgh 4 #fertility2017 Fertility2017 The AssociationACE of Clinical Embryologists CONFERENCE PROGRAMME VENUE PLAN 14.45 Effect of electronic-cigarette flavourings on (I) human sperm motility, chromatin integrity in vitro and (II) mice testicular function in vivo - Helen O’Neill, UCL 15.00 - Sheena Lewis, Sperm DNA quality in Hr6b (Ubiquitin-conjugating enzyme) Knockout Mice: DNA damage study VENUE PLAN Queen’s University Belfast 15.15 DNA sequence analysis of the sperm HALO provides evidence for sequence-specific compartmentalisation of - Adel Binhurahem, University of Leeds PROGRAMME chromatin
Load more

Recommended publications
  • Fertility Service
    James Paget University Hospitals NHS Foundation Trust Fertility Service Information for Patients James Paget University Hospitals’ Fertility Service Index Introduction page 4 The Fertility Team 4 Referral to the Fertility Services 5 Your first appointment 5 Further appointments 6 General information on fertility 6 Preparation for pregnancy 6 For conception to occur 7 Causes of fertility problems 8 - 10 Fertility investigation and treatment 10 - 13 Treatment options available at JPUH 13 Drugs used in fertility treatment at JPUH 15 HFEA licensed infertility treatments via other service providers 16 Useful information 17 - 18 Welcome to the James Paget University Hospitals’ Fertility Service We are located within the Gynaecology Outpatient department which is on the ground floor of the hospital, on the Gynaecology right along the main entrance corridor Outpatients past the Cafe. The contact number is 01493 452366 Open for telephone enquiries: Monday to Thursday 8.30-4.30pm A messaging service is available out-of- hours or if staff are unavailable. Mission Statement The aim of the fertility service is to provide the best possible assessment and treatment for each individual couple and give them the best chance of achieving a pregnancy. We also aim to give as much support as possible to couples where the treatment proves unsuccessful. We welcome any suggestions that you may have to improve the care we provide, especially to reduce the inevitable stress that all couples feel during treatment. The Fertility Team Consultant Gynaecologists Registrar in Gynaecology: (in a rotational post) Fertility Sister Clinic Co-ordinator 4 Referral to the Fertility Service There are set criteria that need to be met for you to be eligible for assessment, and treatment related to fertility.
    [Show full text]
  • Radio 4 Listings for 6 – 12 June 2009 Page 1 of 12 SATURDAY 06 JUNE 2009 Political Correspondent Terry Stiasny and Professor John Claiming a Nazi Pedigree
    Radio 4 Listings for 6 – 12 June 2009 Page 1 of 12 SATURDAY 06 JUNE 2009 Political correspondent Terry Stiasny and Professor John claiming a Nazi pedigree. Curtice discuss increasing pressure placed on the prime minister SAT 00:00 Midnight News (b00kr7fs) after cabinet resignations. Steve speaks to Balham locals, including Radio 4 favourite The latest national and international news from BBC Radio 4. Arthur Smith, and tracks down experts. He explores the reality Followed by Weather. James Naughtie details the ceremonies marking the 65th behind the Nazis' spy operation and their plans for invasion, anniversary of the D-Day landings. gaining privileged access to the original documentation detailing the Third Reich's designs on Britain. SAT 00:30 Book of the Week (b00kvg9j) Correspondent Alex Bushill meets Roger Mansfield, one of the Claire Harman - Jane's Fame first men to try surfing in Cornwall. SAT 11:00 The Week in Westminster (b00krgd6) Episode 5 David Gleave, who runs the consultancy firm Aviation Safety It's been a tumultuous political week in which, for a while, Investigations, discusses news that debris salvaged from the sea Gordon Brown's grip on government appeared to loosen. Alice Krige reads from Claire Harman's exploration of Jane was not from the Air France jet that went missing. Austen's rise to pre-eminence from humble family scribblings A clutch of ministers resigned. But, after carrying out a to Hollywood movies. Samantha Washington, of Money Box, explains claims that car reshuffle, the Prime Minister insisted that HE would not walk insurers are 'bullying' people to settle claims when they have away.
    [Show full text]
  • Understanding Illicit Insemination and Fertility Fraud from Patient Experience to Legal Reform
    Maurer School of Law: Indiana University Digital Repository @ Maurer Law Articles by Maurer Faculty Faculty Scholarship 2020 Understanding Illicit Insemination and Fertility Fraud from Patient Experience to Legal Reform Jody L. Madeira Indiana University Maurer School of Law, [email protected] Follow this and additional works at: https://www.repository.law.indiana.edu/facpub Part of the Intellectual Property Law Commons, Law and Gender Commons, and the Sexuality and the Law Commons Recommended Citation Madeira, Jody L., "Understanding Illicit Insemination and Fertility Fraud from Patient Experience to Legal Reform" (2020). Articles by Maurer Faculty. 2902. https://www.repository.law.indiana.edu/facpub/2902 This Article is brought to you for free and open access by the Faculty Scholarship at Digital Repository @ Maurer Law. It has been accepted for inclusion in Articles by Maurer Faculty by an authorized administrator of Digital Repository @ Maurer Law. For more information, please contact [email protected]. 110 COLUMBIA JOURNAL OF GENDER AND LAW 39.1 UNDERSTANDING ILLICIT INSEMINATION AND FERTILITY FRAUD, FROM PATIENT EXPERIENCE TO LEGAL REFORM JODY LYNEE MADEIRA Abstract Recently, several cases have been filed in North America and Europe alleging that fertility physicians inseminatedformer patients with their own sperm only to have this conduct come to light decades later when their unsuspecting adult children use direct-to- consumer genetic tests and learn that they are not biologically relatedto theirfathers and often that they have multiple half-siblings. For instance, DonaldCline of Indianapolis, Indiana, has over sixty doctor-conceivedchildren, with more continuing to come forward. Although these cases induce disgust, it has thusfar proven dificult to hold these physicians legally accountable because their conductfalls within gaps in existing civil and criminal laws.
    [Show full text]
  • Are Egg Donors Liable for Latent Genetic Disease Suriya E.P
    American University Law Review Volume 58 | Issue 2 Article 4 2008 Guarantors of Our Genes: Are Egg Donors Liable for Latent Genetic Disease Suriya E.P. Jayanti The American University Washington College of Law, [email protected] Follow this and additional works at: http://digitalcommons.wcl.american.edu/aulr Part of the Family Law Commons, and the Torts Commons Recommended Citation Jayanti, Suriya E.P. "Guarantors of Our Genes: Are Egg Donors Liable for Latent Genetic Disease?" American University Law Review 58, no. 2 (December 2008): 405-457. This Comment is brought to you for free and open access by the Washington College of Law Journals & Law Reviews at Digital Commons @ American University Washington College of Law. It has been accepted for inclusion in American University Law Review by an authorized administrator of Digital Commons @ American University Washington College of Law. For more information, please contact [email protected]. Guarantors of Our Genes: Are Egg Donors Liable for Latent Genetic Disease Abstract Assisted reproductive technology ("ART"), including egg donation, is changing the topography of the American family. Heated debates and legislative battles over cloning and stem cell research reveal the complexity of the moral, scientific, nda legal implications of emerging alternative reproductive methods. In fact, the field of reproductive medicine is the "Wild West" of the healthcare world where technological development is testing the boundaries of science and ethics. The legal and ethical issues intrinsic to the evolution of the egg donation industry are poised to become central topics of public debate as we, as a culture, reevaluate who and what constitutes a "parent" or "child," whether a human egg is a commodity, and what privacy and medical confidentiality mean relative to the right to know one's genetic make-up.
    [Show full text]
  • Issues Surrounding the Use and Handling of Cryopreserved Genetic Material
    Legal Aspects of Third Party Reproduction: Issues Surrounding the Use and Handling of Cryopreserved Genetic Material Gary A. Debele Attorney at Law Walling, Berg & Debele, P.A. 121 South Eighth Street, Suite 1100 Minneapolis, Minnesota 55402 (612) 335-4288 [email protected] www.wbdlaw.com A. Embryos in the news: 1. Amy Eisinger, “Biological clock ticking? What you need to know about freezing your eggs.” The Washington Post, July 27, 2015. 2. ABC News website: “Divorced Couple’s Embryo Feud Could Affect How Fertility Clinics Do Business.” July 14, 2015. 3. Debra Bruno, “Why You Need a Prenup for all of Your Relationships,” Washingtonian, August 12, 2015. 4. Houston.com News, “Program matches families willing to donate embryos to those who want children.” January 15, 2015. 5. Michael Sullivan, “Outside the Womb,” www.lifeofthelaw.org, July 14, 2015. 6. Nick Loeb, “Sofia Vergara’s Ex-Fiancé: Our Frozen Embryos Have a Right to Live,” The New York Times, April 29, 2015. 7. Tamar Lewin, “Chicago Court Gives Woman Frozen Embryos Despite Ex-Boyfriend’s Objections,” The New York Times, June 12, 2015. 8. Maura Dolan, “Divorced couple fighting in court over frozen embryos,” L.A. Times, July 13, 2015. 9. Tamar Lewin, Industry’s Growth Leads to Leftover Embryos, and Painful Choices,” The New York Times, June 17, 2015. 10. Angela Pittenger, “Building families through embryo adoption,” tucson.com, July 4, 2015. 11. Ellen McCarthy, “Fertility medicine brings babies -- and tough decisions.” The Washington Post, May 18, 2015; reprinted as “What to do with a leftover embryo?” in Minneapolis Star Tribune, June 8, 2015.
    [Show full text]
  • Serum Human Chorionic Gonadotropin Level After Ovulation Triggering Is Influenced by the Patient’S Body Mass Index and the Number of Larger Follicles
    REPRODUCTIVE ENDOCRINOLOGY Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles Laura Detti, M.D., Mohamed F. M. Mitwally, M.D., Anuradha Rode, M.D., Frank D. Yelian, M.D., Ph.D., Michael Kruger, M.A., Michael P. Diamond, M.D., and Elizabeth E. Puscheck, M.D. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, and the University Women’s Center, Wayne State University School of Medicine, Detroit, Michigan Objective: To identify determinants of the serum concentration of hCG levels after triggering of ovulation with exogenous hCG during controlled ovarian stimulation cycles for in vitro fertilization with or without intracytoplasmic sperm injection. Design: Retrospective cohort study. Setting: University Medical Center. Patient(s): One hundred-fifteen women who underwent conventional in vitro fertilization/intracytoplasmic sperm injection cycles from March 2003 to March 2005. Intervention(s): All patients underwent ovarian hyperstimulation with gonadotropins and GnRH-antagonist for pituitary downregulation. Patients were started on oral contraceptives 1 month before the stimulation. Gonado- tropins were administered from stimulation day 1 until the day of the hCG trigger, and GnRH-antagonist was added from the day when at least one follicle reached 14 mm in diameter and continued until hCG administration. The hCG was administered in 5,000-IU, 10,000-IU, or 15,000-IU doses on the day of ovulation triggering. Main Outcome Measure(s): We performed a stepwise multiple regression analysis to predict which variable would influence the serum concentration of hCG when measured the day after the administration of exogenous hCG.
    [Show full text]
  • Donor Eggs for the Treatment of Infertility
    CLINICAL Caitlin Dunne, MD, FRCSC Donor eggs for the treatment of infertility Using donated eggs can be a remarkably successful fertility treatment in the right circumstances. Though donor egg pregnancies may carry some increased obstetrical risks, the risks are manageable and can offer women a chance at pregnancy when there is no other option. ABSTRACT: Egg donation is a common treatment the right time to recover the resulting embryo, Columbia has the highest age of first birth in for infertility. It is most often used for women with which was transferred into the intended moth- Canada at 30.5 years versus 30.3 years in On- premature menopause, advanced reproductive er’s uterus.2,3 tario.10 According to Statistics Canada, 2010 age, or a history of unsuccessful in vitro fertilization In the early 1980s, assisted reproductive marked the first time that more women in their attempts. Because egg donors are generally in their technology was developing rapidly in Canada 30s were having children compared to women 20s, pregnancy success rates are high. In many cas- and around the world.4 Fertility pioneers used in their 20s.11 es, donor eggs give women a chance at pregnancy laparoscopy to retrieve donor eggs for fertiliza- The possible consequences of delaying child- when there would be no other option. Donor egg tion in vitro.3,5,6 These early “third-party repro- bearing are infertility, embryo aneuploidy, and pregnancies may carry some increased obstetrical duction” techniques were groundbreaking at miscarriage. These are largely attributed to aging risks related to preeclampsia and advanced mater- the time, given that the world’s first IVF baby, oocytes with failing meiotic spindles and other nal age.
    [Show full text]
  • Embryo Adoption Faqs Why Choose the Snowflakes® Program? Snowflakes Embryo Adoption Is Uniquely Child-Centered
    Embryo Adoption FAQs Why Choose the Snowflakes® Program? Snowflakes Embryo Adoption is uniquely child-centered. Open Adoption Encouraged We are a child-centered adoption agency and we believe in open adoption when placing kids for adoption. One important lesson our society has learned over the last century is that open adoption is healthier for the children. Adoption professionals agree that children for adoption should know the identity of their biological parents, and should have information regarding their heritage. Nightlight extends this invaluable lesson to our Snowflakes Embryo Adoption program, and provides a safe environment for both the donor and adopting families. Some embryo donation/adoption programs require anonymity, or charge additional fees for services enabling open adoption. Because Nightlight believes strongly in advocating and facilitating open adoption, there is no additional fee. Donated Embryos are not Disbursed Among Multiple Families We are child-centered, and we do our best to keep siblings together. Adoption professionals agree that keeping siblings together is a paramount value. Whether children are adopted from another country, through foster care, or domestic placement, we always work diligently to place all siblings into one adopting family. Nightlight extends this family value to embryo child adoption. Our Snowflakes team provides matching services that take into consideration the preferences of both the donor and the adopting families and then places all of the donor's embryos into that adoptive family's care. Since our program encourages open adoption, communication between matched families will be mutually agreed upon between them. Clearly, limiting the number of families in which full genetic siblings exist is a benefit to all.
    [Show full text]
  • Reproductive Dreams and Nightmares: Sperm Donation in the Age of At-Home Genetic Testing
    Loyola University Chicago Law Journal Volume 51 Issue 3 Spring 2020 Article 5 2020 Reproductive Dreams and Nightmares: Sperm Donation in the Age of At-Home Genetic Testing Nofar Yakovi Gan-Or Follow this and additional works at: https://lawecommons.luc.edu/luclj Part of the Law Commons Recommended Citation Nofar Yakovi Gan-Or, Reproductive Dreams and Nightmares: Sperm Donation in the Age of At-Home Genetic Testing, 51 Loy. U. Chi. L. J. 791 (). Available at: https://lawecommons.luc.edu/luclj/vol51/iss3/5 This Article is brought to you for free and open access by LAW eCommons. It has been accepted for inclusion in Loyola University Chicago Law Journal by an authorized editor of LAW eCommons. For more information, please contact [email protected]. Reproductive Dreams and Nightmares: Sperm Donation in the Age of At-Home Genetic Testing Nofar Yakovi Gan-Or* Recent technological developments surrounding genetic testing pose new challenges to well-established reproductive practices. One current example is the fertility industry’s struggle to maintain gamete donor anonymity against the growing use of direct-to-consumer DNA tests. Consider the widely covered story of Danielle Teuscher, who in 2019 accidentally discovered the identity of her daughter’s anonymous sperm donor after using a 23andMe DNA test. Danielle’s attempt to reach out to the newfound family member was followed by a cease and desist letter from the sperm bank for violating their agreement. In addition, the sperm bank refused to give Danielle the four vials of sperm from the same donor, which she had reserved for future use, thus thwarting her reproductive plans to have genetic siblings for her daughter.
    [Show full text]
  • Medications Used in Fertility Treatment
    Making Family Real This fact sheet provides an overview of the medications that may be prescribed during fertility or IVF treatment, including an explanation of how and why they are used and some of the potential side effects. THE FACTS ABOUT: Medications used in fertility treatment ANTI-OESTROGENS • Breast tenderness Clomiphene Citrate (Clomid), • Abdominal pain Letrozole and Tamoxifen (Seraphene) • Headaches If you have ovulation problems you may be prescribed one • Blurred vision of these drugs to help regulate or induce ovulation. They • Fatigue increase production of the egg containing follicles. They are all widely used. • Depression Administration • Weight gain These agents are taken orally, usually on days 2-6 of the • Ovarian cysts menstrual cycle and work by sending a message to the pituitary gland, telling it that it needs to start secreting, or to secrete There is no link between ovarian cancer and anti-oestrogens. more, follicle stimulating hormone (FSH). With higher levels of FSH in the body, egg production and ovulation are improved. GnRH Agonist (Synarel/Lucrin/ While Clomiphene Citrate and Letrozole can be prescribed for Decapeptyl) as many as six cycles, most experts agree that, if you have not During IVF and IUI treatments, we need the woman to ovulate become pregnant after three cycles, treatment using these at a specified time to have the best chance of positive results. drugs alone will probably not help you. Most women will GnRH (Gonadotrophin Releasing Hormone) agonists are drugs respond to anti-oestrogens and ovulate within the first three that can help to stop premature ovulation and increase the to four cycles.
    [Show full text]
  • Services Provided by the Agency Surrogacy Program
    SERVICES PROVIDED BY THE AGENCY SURROGACY PROGRAM 2. LEGAL SUPPORT: a. Assistance with negotiations between Clients and gestational surrogate(s) and their respective attorneys, if any, regarding the Gestational Carrier Agreement. b. Implementation of the drafting and execution of the Surrogacy Agreement between clients and the surrogate. c. Ongoing communication with the Clients to facilitate any and all legal proceedings necessary in the United States before and after the birth of any child(ren), to assure Clients’ registration as the child(ren)’s sole parents. 3 INSURANCE SUPPORT: a. Initial review, analysis, and summary of the gestational surrogate’s existing health insurance policy. b. Assistance in obtaining alternate coverage subject to the same limitations if there is an express and known exclusion for surrogacy in the gestational carrier’s insurance policy. c. Coordination of communications between the gestational surrogate(s) and their medical insurance representative(s). d. Assistance with finding a term life insurance policy for the gestational surrogate during the pregnancy. THE AGENCY IS NOT AN INSURANCE COMPANY, AGENT OR BROKER AND DOES NOT PROVIDE OR GUARANTEE ANY INSURANCE COVERAGE . 5. FINANCIAL SERVICES: a. Establishment of an expense account (Expense Account) in order to coordinate payment of gestational surrogate program expenses. b. Payment of invoices related to the surrogacy program out of Expense Account funds. c. Reconciliation of all payments made from the Expense Account and .
    [Show full text]
  • Issue #58 Winter 2020 the Magazine from Fertility
    FREE ISSUE #58 WINTER 2020 AFFINITY THE MAGAZINE FROM FERTILITY NETWORK UK fertilitynetworkuk fertilitynetworkUK fertilitynetworkuk.org @fertilityNUK Hello and welcome to the Winter edition of Affinity, Fertility Network’s magazine. This issue coincides with the charity’s annual National Fertility Week, this year 2nd November – 5th November. The aims of the week are threefold: it’s about changing perceptions and raising awareness of fertility issues; it’s also about providing vital support and finally it’s about raising much needed funds to continue the charity’s work. #YouAreNotAlone is our core message. Here’s what we did during Fertility Week: Monday 2nd November #FertilityInequalities To kick-start this important week, we spotlighted inequalities to fair access to fertility treatment for all. We want to see fair and equitable access to NHS fertility treatment regardless of where you live, your race or your sexuality. We highlighted the unacceptable rationing of treatment throughout the UK, the difference in provision between each of the four nations and the postcode lottery in England. We also raised awareness of inequalities in access based on ethnicity and sexuality, of the differences in outcomes for some ethnic groups, and called for fairness for everyone who needs treatment. Tuesday 3rd November #MentalHealthMatters Infertility is not only about physical health, but can take a toll on mental health too. The impact of COVID-19 with clinic closures and reduced capacity on reopening has increased distress for many patients, making our #MentalHealthMatters day more important than ever. We shared testimonials from our community as well as tips from mental health experts about how best to look after yourself.
    [Show full text]